Phase 1 Malignant Neoplasm of Brain Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1Phase 2

A Rollover Study of NBM-BMX in Combination With Temozolomide in Patients With Newly Diagnosed Glioblastoma

Malignant Neoplasm of Brain

Novelwise Pharmaceutical Corporation15 enrolled3 locationsNCT07569042

Recruiting

Phase 1Phase 2

NBM-BMX Administered Orally to Patients With Solid Tumors or Newly Diagnosed Glioblastoma

Malignant NeoplasmMalignant Neoplasm of Brain

Novelwise Pharmaceutical Corporation79 enrolled4 locationsNCT06012695